Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential expression of miR‐21, miR‐125b and miR‐191 in breast cancer tissue

23 Jul 2012

Abstract excerpt

AIMS: To develop new biomarkers for early detection and to inform effective clinical management of breast cancer. METHODS: Real-time polymerase chain reaction was used to profile microRNA (miRNA) in tumor tissue from 50 breast cancer patients using non-tumor breast tissue from each patient as a control. We have focussed on three miRNA; miR-21, miR-125b and miR-191, all of which have been implicated in breast...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circular RNAs in diseases
Share to Cytokine Signaling Pathways and Interactions
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22898264
DOI: 10.1111/j.1743-7563.2012.01548.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential expression of miR‐21, miR‐125b and miR‐191 in breast cancer tissuePMID 22898264Read ↗

The evolving role of microRNA subtypes 21, 155 and 10b as oncogenes and biomarkers in breast cancer in a decade: A systematic review articleSemantic proximity Read ↗

miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development.Semantic proximity Read ↗

Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients.Semantic proximity Read ↗

Serum miR-181а and miR-25 levels in patients with breast cancer or a benign breast diseaseSemantic proximity Read ↗

MicroRNA-21 (miR-21) in breast cancer: From apoptosis dysregulation to therapeutic opportunitiesSemantic proximity Read ↗

Quantitative Measurement of Serum MicroRNA-21 Expression in Relation to Breast Cancer Metastasis in Chinese FemalesSemantic proximity Read ↗

Unravelling the Impact of miR-21 Overexpression on the MicroRNA Network and Cancer PathwaysSemantic proximity Read ↗

Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.Semantic proximity Read ↗

Expression of microRNAs ‘let-7d and miR-195’ and apoptotic genes ‘BCL2 and caspase-3’ as potential biomarkers of female breast carcinogenesisSemantic proximity Read ↗

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancerSemantic proximity Read ↗

miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor PrognosisSemantic proximity Read ↗

Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.